company background image
600566 logo

Hubei Jumpcan Pharmaceutical XSSC:600566 Stock Report

Last Price

CN¥43.96

Market Cap

CN¥40.5b

7D

5.5%

1Y

37.9%

Updated

18 Apr, 2024

Data

Company Financials +

Hubei Jumpcan Pharmaceutical Co., Ltd.

XSSC:600566 Stock Report

Market Cap: CN¥40.5b

600566 Stock Overview

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China.

600566 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance6/6
Financial Health6/6
Dividends4/6

Hubei Jumpcan Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hubei Jumpcan Pharmaceutical
Historical stock prices
Current Share PriceCN¥43.96
52 Week HighCN¥45.18
52 Week LowCN¥23.95
Beta0.16
1 Month Change21.47%
3 Month Change38.11%
1 Year Change37.89%
3 Year Change124.63%
5 Year Change19.36%
Change since IPO102.67%

Recent News & Updates

Recent updates

Shareholder Returns

600566CN PharmaceuticalsCN Market
7D5.5%-1.5%-0.4%
1Y37.9%-16.0%-17.6%

Return vs Industry: 600566 exceeded the CN Pharmaceuticals industry which returned -15.9% over the past year.

Return vs Market: 600566 exceeded the CN Market which returned -17.8% over the past year.

Price Volatility

Is 600566's price volatile compared to industry and market?
600566 volatility
600566 Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement7.9%
Market Average Movement8.9%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 600566's share price has been volatile over the past 3 months.

Volatility Over Time: 600566's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a5,230Fei Caowww.jumpcan.com

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.

Hubei Jumpcan Pharmaceutical Co., Ltd. Fundamentals Summary

How do Hubei Jumpcan Pharmaceutical's earnings and revenue compare to its market cap?
600566 fundamental statistics
Market capCN¥40.52b
Earnings (TTM)CN¥2.82b
Revenue (TTM)CN¥9.65b

14.4x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600566 income statement (TTM)
RevenueCN¥9.65b
Cost of RevenueCN¥1.78b
Gross ProfitCN¥7.87b
Other ExpensesCN¥5.05b
EarningsCN¥2.82b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 20, 2024

Earnings per share (EPS)3.06
Gross Margin81.52%
Net Profit Margin29.24%
Debt/Equity Ratio8.1%

How did 600566 perform over the long term?

See historical performance and comparison

Dividends

3.0%

Current Dividend Yield

42%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.